Back to Search Start Over

Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection.

Authors :
Torrado E
Fountain JJ
Liao M
Tighe M
Reiley WW
Lai RP
Meintjes G
Pearl JE
Chen X
Zak DE
Thompson EG
Aderem A
Ghilardi N
Solache A
McKinstry KK
Strutt TM
Wilkinson RJ
Swain SL
Cooper AM
Source :
The Journal of experimental medicine [J Exp Med] 2015 Aug 24; Vol. 212 (9), pp. 1449-63. Date of Electronic Publication: 2015 Aug 17.
Publication Year :
2015

Abstract

CD4+ T cells mediate protection against Mycobacterium tuberculosis (Mtb); however, the phenotype of protective T cells is undefined, thereby confounding vaccination efforts. IL-27 is highly expressed during human tuberculosis (TB), and absence of IL-27R (Il27ra) specifically on T cells results in increased protection. IL-27R deficiency during chronic Mtb infection does not impact antigen-specific CD4+ T cell number but maintains programmed death-1 (PD-1), CD69, and CD127 expression while reducing T-bet and killer cell lectin-like receptor G1 (KLRG1) expression. Furthermore, T-bet haploinsufficiency results in failure to generate KLRG1+, antigen-specific CD4+ T cells, and in improved protection. T cells in Il27ra(-/-) mice accumulate preferentially in the lung parenchyma within close proximity to Mtb, and antigen-specific CD4+ T cells lacking IL-27R are intrinsically more fit than intact T cells and maintain IL-2 production. Improved fitness of IL-27R-deficient T cells is not associated with increased proliferation but with decreased expression of cell death-associated markers. Therefore, during Mtb infection, IL-27R acts intrinsically on T cells to limit protection and reduce fitness, whereas the IL-27R-deficient environment alters the phenotype and location of T cells. The significant expression of IL-27 in TB and the negative influence of IL-27R on T cell function demonstrate the pathway by which this cytokine/receptor pair is detrimental in TB.<br /> (© 2015 Torrado et al.)

Details

Language :
English
ISSN :
1540-9538
Volume :
212
Issue :
9
Database :
MEDLINE
Journal :
The Journal of experimental medicine
Publication Type :
Academic Journal
Accession number :
26282876
Full Text :
https://doi.org/10.1084/jem.20141520